Penserra Capital Management LLC Buys 23,550 Shares of Amdocs Limited $DOX

Penserra Capital Management LLC raised its stake in Amdocs Limited (NASDAQ:DOX) by 23.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 123,431 shares of the technology company’s stock after purchasing an additional 23,550 shares during the period. Penserra Capital Management LLC owned 0.11% of Amdocs worth $10,127,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Pzena Investment Management LLC increased its position in Amdocs by 2.1% in the 2nd quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company’s stock valued at $597,719,000 after buying an additional 132,463 shares in the last quarter. LSV Asset Management grew its stake in Amdocs by 6.6% in the second quarter. LSV Asset Management now owns 3,391,510 shares of the technology company’s stock valued at $309,441,000 after acquiring an additional 211,009 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Amdocs by 3.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,111,312 shares of the technology company’s stock valued at $252,856,000 after acquiring an additional 91,428 shares in the last quarter. Brandes Investment Partners LP increased its holdings in shares of Amdocs by 1.2% during the second quarter. Brandes Investment Partners LP now owns 2,328,804 shares of the technology company’s stock valued at $212,481,000 after acquiring an additional 27,581 shares in the last quarter. Finally, Nordea Investment Management AB raised its position in shares of Amdocs by 18.0% during the second quarter. Nordea Investment Management AB now owns 1,879,023 shares of the technology company’s stock worth $170,803,000 after purchasing an additional 287,235 shares during the period. Institutional investors and hedge funds own 92.02% of the company’s stock.

Key Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Q1 results beat consensus — Amdocs reported $1.81 EPS on $1.16B revenue, above estimates and up year-over-year, which supports the business outlook and helped lift sentiment initially. Amdocs (DOX) Q1 2026 Earnings Call Transcript
• Positive Sentiment: Large customer win and commercial traction — Amdocs extended a multi-year strategic deal with T‑Mobile (managed services, software, AI work including UScellular integration), reinforcing recurring revenue and services demand. T‑Mobile USA Enters Strategic Multi-Year Agreement with Amdocs
• Positive Sentiment: Product / market expansion — Amdocs launched aOS (agentic OS for telecom) and won a MarketONE deal with VIDAA for OTT bundled experiences, highlighting its push into AI-enabled telecom automation and media monetization. These should support longer-term growth and cross-sell. Amdocs Introduces aOS VIDAA Selects Amdocs MarketONE
• Positive Sentiment: Dividend increase — Board raised the quarterly dividend ~8% to $0.569 (annualized yield ~3.1%), which supports income-oriented investor demand and signals confidence in cash flow.
• Neutral Sentiment: FY26 guidance and Q2 outlook were updated (FY EPS range 7.27–7.55; Q2 EPS 1.73–1.79). On the surface ranges are near or above consensus, but language and trajectory prompted mixed interpretation by the market. Amdocs FY26 Guidance / Press Release
• Neutral Sentiment: Analyst action — Stifel cut its price target from $97 to $88 but maintained a Buy rating, reflecting mixed analyst views (valuation trimmed but still upside). Stifel Lowers PT on Amdocs
• Negative Sentiment: Management transition fuels uncertainty — Long-time CEO Shuky Sheffer will retire March 31; Shimie Hortig will succeed him. Leadership change at the top can increase short-term execution risk and investor uncertainty. Amdocs Appoints Shimie Hortig as CEO Amdocs Announces CEO Succession
• Negative Sentiment: Market reaction — Headlines tying the CEO transition and perceived guidance tightening to a downgrade in confidence prompted a notable share pullback (coverage noted a ~10% drop on related headlines), indicating short-term risk to the stock. Amdocs Is Down After Lowering Guidance and Announcing CEO Transition

Amdocs Stock Performance

DOX stock opened at $73.06 on Thursday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.23. The firm has a market cap of $7.89 billion, a PE ratio of 14.13, a P/E/G ratio of 1.25 and a beta of 0.40. The business has a 50 day moving average of $80.31 and a 200-day moving average of $82.57. Amdocs Limited has a 12-month low of $70.32 and a 12-month high of $95.41.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 20.13% and a net margin of 12.47%.The business’s revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, sell-side analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 3.1%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio is 40.81%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Bank of America lowered their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday, November 12th. Stifel Nicolaus lowered their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Finally, Barclays set a $92.00 target price on Amdocs in a report on Wednesday. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.